(Q38068957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

1 reference

title

Crohn's as an immune deficiency: from apparent paradox to evolving paradigm (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Marcel A Behr

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

17-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

Inborn errors of anti-viral interferon immunity in humans

21 February 2020

cites work

1 reference

Primary immunodeficiencies: a field in its infancy

21 January 2018

1 reference

"Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis

21 January 2018

1 reference

Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics

21 January 2018

1 reference

Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency

21 January 2018

1 reference

Genetics of monogenic autoinflammatory diseases: past successes, future challenges

21 January 2018

1 reference

Autoimmune manifestations in primary immune deficiencies

21 January 2018

1 reference

Primary immunodeficiency and autoimmunity: lessons from human diseases

21 January 2018

1 reference

Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions

21 January 2018

1 reference

Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia

21 January 2018

1 reference

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

21 January 2018

1 reference

Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)

21 January 2018

1 reference

Telomeres and marrow failure

21 January 2018

1 reference

Common symptoms and stressors among individuals with inflammatory bowel diseases.

21 January 2018

1 reference

Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

21 January 2018

1 reference

Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes

21 January 2018

1 reference

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

21 January 2018

1 reference

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis

21 January 2018

1 reference

Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.

21 January 2018

1 reference

Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease

21 January 2018

1 reference

Corticosteroid therapy for liver abscess in chronic granulomatous disease

21 January 2018

1 reference

Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy.

21 January 2018

1 reference

Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy

21 January 2018

1 reference

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

Update on the diagnosis and treatment of Pneumocystis pneumonia.

21 January 2018

1 reference

Gastrointestinal involvement in chronic granulomatous disease

21 January 2018

1 reference

Colitis in chronic granulomatous disease

21 January 2018

1 reference

Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease

21 January 2018

1 reference

Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease

21 January 2018

1 reference

Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review

21 January 2018

1 reference

Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency

21 January 2018

1 reference

Chronic granulomatous disease. Report on a national registry of 368 patients

21 January 2018

1 reference

Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.

21 January 2018

1 reference

Colitis complicating chronic granulomatous disease. A clinicopathological case report

21 January 2018

1 reference

CD68 expression is markedly different in Crohn's disease and the colitis associated with chronic granulomatous disease.

21 January 2018

1 reference

Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis

21 January 2018

1 reference

Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors

21 January 2018

1 reference

Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor

21 January 2018

1 reference

Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease

21 January 2018

1 reference

Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD).

21 January 2018

1 reference

NADPH oxidase limits innate immune responses in the lungs in mice

21 January 2018

1 reference

Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus

21 January 2018

1 reference

Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice

21 January 2018

1 reference

Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease

21 January 2018

1 reference

Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b.

21 January 2018

1 reference

Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.

21 January 2018

1 reference

High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease

21 January 2018

1 reference

Antibodies to CBir1 are associated with glycogen storage disease type Ib.

21 January 2018

1 reference

Defective acute inflammation in Crohn's disease: a clinical investigation

21 January 2018

1 reference

Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.

21 January 2018

1 reference

Neutrophil dysfunction in Crohn's disease

21 January 2018

1 reference

Leucocyte function in Crohn's disease. Studies on mobilisation using a quantitative skin window technique and on the function of circulating polymorphonuclear leucocytes in vitro

21 January 2018

1 reference

Neutrophil motility in Crohn's disease

21 January 2018

1 reference

The neutrophil respiratory burst and bacterial digestion in Crohn's disease

21 January 2018

1 reference

Residual NADPH oxidase and survival in chronic granulomatous disease

21 January 2018

1 reference

Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease

21 January 2018

1 reference

Defective tumor necrosis factor release from Crohn's disease macrophages in response to Toll-like receptor activation: relationship to phenotype and genome-wide association susceptibility loci

21 January 2018

1 reference

Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease

21 January 2018

1 reference

Therapy options in pulmonary alveolar proteinosis.

21 January 2018

1 reference

IRF8 mutations and human dendritic-cell immunodeficiency

21 January 2018

1 reference

The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency

21 January 2018

1 reference

The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases

21 January 2018

1 reference

Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases

21 January 2018

1 reference

21 January 2018

1 reference

Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids

21 January 2018

1 reference

Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations

21 January 2018

1 reference

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47

21 January 2018

1 reference

Human IRGM induces autophagy to eliminate intracellular mycobacteria

21 January 2018

1 reference

Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility

21 January 2018

1 reference

Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry

21 January 2018

1 reference

NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation

21 January 2018

1 reference

Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease

21 January 2018

1 reference

NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2

21 January 2018

1 reference

Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease

21 January 2018

1 reference

Prevalence of CARD15/NOD2 mutations in Caucasian healthy people

21 January 2018

1 reference

Autophagy in immunity and inflammation

21 January 2018

1 reference

Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors.

21 January 2018

1 reference

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

21 January 2018

1 reference

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

21 January 2018

1 reference

Crohn's disease and the NOD2 gene: a role for paneth cells

21 January 2018

1 reference

The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells

21 January 2018

1 reference

NOD2 regulates hematopoietic cell function during graft-versus-host disease

21 January 2018

1 reference

NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression

21 January 2018

1 reference

Reduced Paneth cell alpha-defensins in ileal Crohn's disease

21 January 2018

1 reference

A new look at Crohn's disease: breakdown of the mucosal antibacterial defense

21 January 2018

1 reference

21 January 2018

1 reference

Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system

21 January 2018

1 reference

Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide

21 January 2018

1 reference

NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis

21 January 2018

1 reference

Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A.

21 January 2018

1 reference

NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation

21 January 2018

1 reference

A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide

21 January 2018

1 reference

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

21 January 2018

1 reference

Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis

21 January 2018

1 reference

Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection

21 January 2018

1 reference

Genomewide association study of leprosy

21 January 2018

1 reference

Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states

21 January 2018

1 reference

Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans

21 January 2018

1 reference

NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis

21 January 2018

1 reference

NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages

21 January 2018

1 reference

Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay

21 January 2018

1 reference

Adult-onset immunodeficiency in Thailand and Taiwan

21 January 2018

1 reference

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

Fungal infection in chronic granulomatous disease

21 January 2018

1 reference

Inherited defects causing hemophagocytic lymphohistiocytic syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.12.87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23256761%20AND%20SRC:MED&resulttype=core&format=json